Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNERGY: TBAJ-587 in Newly Diagnosed, Drug-Sensitive, Sputum-Positive Pulmonary Tuberculosis
NCT07773610Phase 2Not yet recruiting
- Sponsor
- TASK Foundation
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of TBAJ-587 in pulmonary tuberculosis (TB), sponsored by TASK Foundation. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
TBAJ-587
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT07773610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07773610.